(EMAILWIRE.COM, April 19, 2008 ) On April 15, 2008, the FDA announced that the blood thinner heparin, which has been associated with several deaths and allergic reactions, may have been intentionally contaminated in order to reduce the cost of the drug. The contaminated heparin was manufactured by Baxter International and is commonly used before certain types of surgery and during hemodialysis as a blood clotting preventative.

In addition, the FDA reported last week that there has been a substantial increase in the number of people who have died while taking the blood thinner. Its findings indicated that there have been 103 reports of heparin-associated deaths since January 1, 2007 and 91 of these were reported to the agency on or after January 1, 2008. Baxter and the FDA recalled several dosage types of heparin in February after receiving reports of adverse reactions including breathing difficulty, vomiting, excess sweating and a rapid decline in blood pressure. Baxter subsequently expanded the recall to include all remaining lots of its multi-dose, single dose and flush products.

The law firm of Cohen, Placitella & Roth is actively seeking referrals of cases that resulted in death or injury of individuals who were administered heparin. If you would like additional information concerning this litigation, please contact Stewart Cohen at 215-567-3500 or scohen@cprlaw.com.

http://www.cprlaw.com/Heparin-Recall-Contamination.cfm

Contact Information:
Lawyer Central
Marc Lippman
Tel: 908-222-8848
Email us